Poland· PL-100469701

Wellbutrin XR

A bupropion product containing bupropioni hydrochloridum, registered in Poland by Procareplus Pharma S.A.. The same ATC class is registered in 13 of our 19 countries.

ATC N06AX12

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedWellbutrin XRATCN06AX12REGISTER NO.PL-100469701PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Bupropion is registered in 13 of 19 countries.

Countries holding a registration under ATC N06AX12 (bupropion), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 9 of them publish a price we can compare per daily dose

Bupropion · ATC N06AX12

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of bupropion costs, country by country.

Normalised to the WHO defined daily dose (0.15 g), the median price runs from $0.10 in United States to $1.25 in Switzerland — a ×12 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Bupropion · price per daily dose (0.15 g)

USD · FX 28 Sept 2026

  • CH Switzerland$1.25
  • IT Italy$0.90
  • US United States$0.10 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Bupropioni hydrochloridum
Manufacturer
Procareplus Pharma S.A.
Country
Poland (PL)
ATC code
N06AX12
ATC class
Bupropion
Defined daily dose
0.15 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909991485771

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

808 interactions on record for bupropion.

Graded by severity as the source publishes them — 230 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Bupropion · interactions on record

808 records

  • 230 severe
  • 217 moderate
  • 4 minor
  • 316 info

Most severe, free to view

  • MetoclopramideA03FA01severe
  • OndansetronA04AA01severe
  • GranisetronA04AA02severe
  • DolasetronA04AA04severe

41 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Bupropion in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bupropion products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Bupropion !$tada, Bupropion +pharma
  • Belgium · Bupropion Eg, Bupropion Sandoz
  • Cyprus · Wellbutrin Xr
  • Czechia · Bupropion +pharma, Bupropion Neuraxpharm
  • Germany · Bupropion, Bupropion 1 A Pharma
  • Denmark · Bupropion Hydrochloride Zentiva, Bupropionhydrochlorid Stada
  • Estonia · Elontril
  • Spain · Bupropion Accord, Bupropión Cinfa
  • Finland · Bupropion Accord, Bupropion Omet Pharma
  • France · Zyban L.P.
  • United Kingdom (Northern Ireland) · Zyban
  • Greece · Wellbutrin Xr
  • Croatia · Bupropion Genericon, Wellbutrin Xr
  • Hungary · Elontril
  • Ireland · Zyban
  • Iceland · Bupropion Teva, Wellbutrin Retard
  • Italy · Bupropion Sun, Bupropione Doc
  • Lithuania · Elontril
  • Luxembourg · Bupropion Eg, Bupropion Ratiopharm
  • Latvia · Wellbutrin Sr
  • Malta · Bupropion Generis, Wellbutrin Xr
  • Netherlands · Bupropion Hcl 1a Retard 1a Pharma, Bupropion Hcl Accord
  • Norway · Bupropion Hydrochloride Teva, Bupropion Hydrochloride Zentiva
  • Portugal · Bupropiom Generis, Bupropiom Ratiopharm
  • Romania · Axabal, Elontril
  • Sweden · Bupropion Accord, Bupropion Bluefish
  • Slovenia · Bupropion Accord, Wellbutrin Xr
  • Slovakia · Bupropion Neuraxpharm, Elontril

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ce7c0d20-c914-45fb-ac0e-047f37a904f3
GET /v1/drugs/ce7c0d20-c914-45fb-ac0e-047f37a904f3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki o zmodyfikowanym uwalnianiu",
  "source": "urpl",
  "strength": "150 mg",
  "packaging": "05909991485771 ¦ Rp ¦ 145356\n30 tabl.",
  "substance": "Bupropioni hydrochloridum 150 mg",
  "common_name": "Bupropioni hydrochloridum",
  "pl_product_id": "100469701",
  "pozwolenie_nr": "248/22",
  "auth_procedure": "IR",
  "authorisation_validity": "2027-06-07"
}

See everything about bupropion.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.